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Kininogens are multifunctional proteins involved in a variety of regulatory pro-
cesses including the kinin-formation cascade, blood coagulation, fibrynolysis, inhibi-
tion of cysteine proteinases etc. A working hypothesis of this work was that the prop-
erties of kininogens may be altered by oxidation of their methionine residues by reac-
tive oxygen species that are released at the inflammatory foci during phagocytosis of
pathogen particles by recruited neutrophil cells. Two methionine-specific oxidizing
reagents, N-chlorosuccinimide (NCS) and chloramine-T (CT), were used to oxidize the
high molecular mass (HK) and low molecular mass (LK) forms of human kininogen. A
nearly complete conversion of methionine residues to methionine sulfoxide residues
in the modified proteins was determined by amino acid analysis. Production of kinins
from oxidized kininogens by plasma and tissue kallikreins was significantly lower (by
at least 70%) than that from native kininogens. This quenching effect on kinin release
could primarily be assigned to the modification of the critical Met-361 residue adja-
cent to the internal kinin sequence in kininogen. However, virtually no kinin could be
formed by human plasma kallikrein from NCS-modified HK. This observation sug-
gests involvement of other structural effects detrimental for kinin production. In-
deed, NCS-oxidized HK was unable to bind (pre)kallikrein, probably due to the modifi-
cation of methionine and/or tryptophan residues at the region on the kininogen mole-
cule responsible for the (pro)enzyme binding. Tests on papain inhibition by native and
oxidized kininogens indicated that the inhibitory activity of kininogens against
cysteine proteinases is essentially insensitive to oxidation.
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Oxidation of proteins may occur in the or-
ganism wherever the concentration of suit-
able oxidants increases over the basal level.
For example, at the inflammatory foci, a num-
ber of reactive oxygen species including
superoxide anion and hydroxyl radicals, hy-
drogen peroxide, hypochlorous acid, etc. are
released during fagocytosis of pathogen parti-
cles by recruited neutrophil cells (Babior,
1978; Li et al., 1996). On the protein mole-
cules, the methionine and cysteine residues
are particularly susceptible to oxidation by
these destructive factors (Vogt, 1995). The ox-
idation of important regulatory proteins may
have serious consequences for the homeosta-
sis of the body. Spectacular examples of the ef-
fects exerted via protein methionine oxidation
to methionine sulfoxide (MSO) include the in-
activation of neutrophil elastase-controlling
1-proteinase inhibitor (Johnson & Travis,
1979; Ossanna et al., 1986), 2-macroglobulin
(Reddy et al., 1994) and other plasma pro-
teinase inhibitors (Swain & Pizzo, 1988), inac-
tivation of numerous hormones including hu-
man growth hormone (Teh et al., 1987), ovine
prolactin (Houghten & Li, 1976) or
parathyroid hormone (Hong et al., 1986) but,
on the other hand, activation of C5 compo-
nent of human complement (Vogt et al., 1992),
etc.
A working hypothesis of this work was that
mild oxidation of methionine residues might
affect the properties of kininogens, multi-
functional proteins involved in kinin forma-
tion, blood coagulation, fibrynolysis and inhi-
bition of cysteine proteinases (Colman, 1994;
Colman & Schmaier, 1997). Kinins (brady-
kinin and kallidin), universal mediators of in-
flammation, are bioactive peptides that are ex-
cised from kininogens by serine proteinases
called kallikreins (Bhoola et al., 1992). Brady-
kinin (RPPGFSPFR) is produced from a high
molecular mass form of human kininogen
(HK) by plasma kallikrein (HPK). Formation
of a tight complex of HK with prekallikrein
(pre-HPK), a zymogen form of HPK, is essen-
tial for its activation (Colman & Schmaier,
1997; Joseph et al., 2001) and the active HPK
remains tightly bound to HK. Another, low
molecular mass form of kininogen (LK) can-
not be processed by HPK but is a source of
kallidin (KRPPGFSPFR) upon the action of a
tissue-specific kallikrein (Margolius, 1998). In
contrast to HK, LK does not posses any dis-
tinct kallikrein-binding domain.
In the primary structure of human kini-
nogens, a methionine residue is adjacent to
the N-terminus of the internal kallidin se-
quence. The hypothesis that the oxidation of
this particular residue may affect the kinin
production by kallikreins was recently tested
with model peptides ISLMKRPPGFSPFRSSI
and ISL(MSO)KRPPGFSPFRSSI (Kozik et
al., 1998). Both types of kallikreins were es-
sentially unable to process the kinin
N-terminus in the MSO-containing peptide. It
was additionally shown that HK that was oxi-
dized with N-chlorosuccinimide (NCS) could
hardly be processed by kallikreins. Unfortu-
nately, no attempt to interpret that finding in
terms of protein chemistry was made. Also,
the effect of methionine oxidation in LK on
kinin formation was not described, and the
other possible influences of kininogen oxida-
tion on the physiologically important proper-
ties of these multifunctional proteins were not
characterized.
In this work we modified both forms of hu-
man kininogen with two methionine-oxidizing
agents, NCS and chloramine-T (CT), deter-
mined the oxidation status of methionine-re-
sidues in the modified proteins and described
in more detail the effects of kininogen oxida-
tion on the kinin formation by kallikreins, on
the complex formation between HK and HPK
and on the cysteine proteinase (papain) inhibi-
tion by kininogens.
MATERIALS AND METHODS
Materials. N--benzoyl-DL-arginine p-nitro-
anilide (BAPNA), bradykinin, cysteine, CT,
dimethylsulfoxide (Me2SO), human plasma
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LK, HPK, kallidin, NCS, papain (type III) and
sequanal grade trifluoroacetic acid (TFA)
were obtained from Sigma (St. Louis, MO,
U.S.A.), single chain HK from human plasma
and pre-HPK were from Calbiochem (San
Diego, CA, U.S.A.), and high-performance liq-
uid chromatography (HPLC) gradient grade
methanol and acetonitrile were purchased
from Merck (Darmstadt, Germany). Human
neutrophil elastase (HNE) and porcine pan-
creatic kallikrein (PPK) were kindly provided
by Dr. Jan Potempa (Jagiellonian University,
Kraków, Poland) and Dr. Hans Fritz (Univer-
sity of Munich, Munich, Germany), respec-
tively. The kinin-containing heptadekapeptide
SL(MSO)KRPPGFSPFRSSRI was synthe-
sized at the Molecular Genetics Instrumental
Facility (University of Georgia, Athens, GA,
U.S.A.) using the standard Fmoc (N-(9-fluo-
renyl)methoxycarbonyl) protocol with an Ad-
vanced ChemTech MPS350 automated syn-
thesizer. HPLC-grade water was obtained by
purification in a MilliQ plus (Millipore, Bed-
ford, MA, U.S.A.) system. Standard chemicals
were of ACS grade from Sigma, Merck and
Amresco (Solon, OH, U.S.A.).
Chemical oxidation of kininogens. Kini-
nogens (HK or LK) at a concentration of 2.5
M in 0.05 M Hepes buffer pH 7.0, containing
0.15 M NaCl, were incubated with 0.625 mM
NCS (added as a freshly prepared solution in
the Hepes buffer) for 2 h at 37C, with occa-
sional stirring. Methionine (solution in the
Hepes buffer) was then added to a concentra-
tion of 9 mM and the sample was further incu-
bated for 0.5 h at 37C. In some experiments,
NCS concentration was varied (0.07 to 6.25
mM).
Modification of kininogens with CT (Schech-
ter et al., 1975) was performed at the protein
concentration of 2.5 M in 0.05 M Tris/HCl
buffer pH 8.5. CT (fresh solution in the same
buffer) was added to a concentration of 0.57
mM (or varied within the range of 0.1–4 mM)
and the sample was incubated for 20 min at
room temperature with occasional stirring.
Finally, the reaction was quenched with
methionine (9 mM) for 10 min at room tem-
perature.
Proteolytic processing of native or oxi-
dized kininogens. Kininogens (1 M) were
treated with kallikreins (0.05 M) in 0.05 M
Hepes buffer pH 7.0, containing 0.15 M NaCl,
at 37C, with occasional stirring. After the de-
sired time, aliquots of the incubation mixture
were withdrawn, mixed with one-fifth volume
of 1 M HCl and stored frozen until the HPLC
analysis for kinin content.
In some experiment, NCS-modified HK was
first pre-digested with HNE (0.02 M) in the
Hepes buffer for 2 h at 37C before addition of
HPK (0.05 M) and further incubation at the
same temperature.
Reversed-phase HPLC of kinins and re-
lated peptides. Bradykinin and kallidin re-
leased from kiniogens by kallikreins were de-
termined by reversed-phase HPLC analysis on
a Supelcosil LC-318 (ODS) column (4 mm 
250 mm) equipped with a Supelguard LC-318
cartridge precolumn (4 mm  20 mm), in a bi-
nary gradient developed between 0.1% TFA in
water (solvent A) and 0.08% TFA in 80%
acetonitrile (solvent B). The separations were
performed at a flow rate of 1 ml/min at ambi-
ent temperature, with detection at 215 nm.
The gradient applied was linear, starting from
10% B, with a slope of +1.5% B per minute. Sol-
vents were filtered through 0.45 m Nylon fil-
ters (Supelco) and degassed with helium.
Samples were centrifuged for 2 min at 10000
 g at ambient temperature, and placed in
autosampler vials from which, typically,
70–90 l portions were withdrawn for injec-
tion. A Shimadzu liquid chromatograph series
10A VP was used that contained: (i) a
high-pressure binary gradient forming sol-
vent delivery system based on two LC-10AD
VP pumps, (ii) a SIL-10AD VP autosampler,
(iii) an SPD-10A VP two-channel variable
wavelength spectrophotometric detector, (iv)
an SCL-10A VP system controller, and (v) a
Class VP (ver. 5.0) hardware/software pack-
age for system control and data acquisition/
analysis.
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Another reversed-phase HPLC system
(Kozik et al., 1998) was applied for the identifi-
cation of the peptide SL(MSO)KRPPGFSPFR
in the samples of HK, sequentially digested
with HNE and HPK. A LiChro-CART LiChro-
sphere 100 RP-18 250 mm  4 mm column
(Merck) with a precolumn was applied. Sol-
vent A was 0.1% TFA in water, solvent B was
0.1% TFA in 80% methanol. The separations
were performed isocratically (53% B) at a flow
rate of 1 ml/min at ambient temperature,
with detection at 215 nm. The HPLC instru-
ment used consisted of: (i) a Shimadzu
DGU-14A solvent degasser, (ii) a Shimadzu
low-pressure quaternary gradient solvent de-
livery unit (LC-9A HPLC pump and FCV-9AL
proportioning valve), (iii) a Knauer model
A0263 injector equipped with a 100 l sample
loop, (iv) a Merck-Hitachi L-4000A UV detec-
tor, and (v) Schimadzu Class VP (v. 4.0) hard-
ware/software package for pump control,
data acquisition and analysis.
Gel filtration of mixtures of pre-HPK
with native or oxidized HK. Pre-HPK (1.5
M) was incubated with native or oxidized HK
(1 M) in 0.05 M Hepes buffer pH 7.0, contain-
ing 0.15 M NaCl for 1 h and room tempera-
ture. Samples were filtered through Millex
HV 0.45 m filters with low protein binding
Durapore membrane (Millipore, Bedford,
U.S.A.) and subjected to high-resolution gel
filtration on a Superdex-200 HR 10/30 col-
umn (Pharmacia, Uppsala, Sweden) eluted
with 0.05 M sodium phosphate buffer pH 7.0
containing 0.15 M NaCl at a flow rate of 0.5
ml/min at ambient temperature. The chro-
matographic system used consisted of: (i) a
Well Chrom K-1001 HPLC pump (Knauer,
Germany), (ii) a Rheodyne 9725 injector
equipped with a 200 l sample loop, (iii) a
UV-1 photometric monitor (Pharmacia), and
(iv) Chromed PC software (Poznañ, Poland)
for data acquisition and analysis. The column
was calibrated with a Bio-Rad molecular mass
standard mixture containing thyroglobulin
(670 kDa), -globulin (158 kDa), ovalbumin
(44 kDa) and myoglobin (17 kDa).
Papain inhibition assay. Papain (Sigma
type III), supplied as a solution of 25 mg/ml in
0.05 M sodium acetate buffer pH 4.5, contain-
ing 0.01% thymol, was diluted 20-fold into
0.05 M sodium phosphate buffer pH 6.8, con-
taining 10 mM EDTA and 5 mM cysteine. The
sample was incubated for 30 min at 37C for
enzyme activation. The activated papain solu-
tion (5 l), 2.5 M native or oxidized kini-
nogen solution (3–20 l) and 0.05 M sodium
phosphate buffer pH 6.8 with 10 mM EDTA
and 5 mM cysteine added to the final volume
of 200 l were mixed in the wells of a 96-well
flat-bottom NUNCLON cell culture microplate
(Nalge Nunc, Denmark). The plate was incu-
bated for 30 min at 37C and then placed in
the thermostated chamber of a Bio-Tek
PowerWave X–Select scanning microplate
reader (Winooski, VE, U.S.A.) set at the same
temperature. After 5 min, 4 l portions of
BAPNA solution (50 mM in Me2SO) were
added to each well and a continuous monitor-
ing of absorbance at 410 nm was started. The
mean reaction rate was calculated from the
linear part of the time course of absorbance
increase and was used as a measure of the en-
zyme activity.
Amino acid analysis. Amino acid analysis
was performed according to protocols de-
scribed by Cohen et al. (1989). Briefly, protein
samples were subjected to gas-phase hydroly-
sis in 6 M HCl at 115C for 24 h and the amino
acids released were converted to phenylthio-
carbamyl (PTC) derivatives. PTC-amino acids
were then analysed on a PicoTag 3.9  150
mm column (Waters, U.S.A.) using a Waters
HPLC system equipped with a 490E-type
UV/VIS detector and two 501-type pumps.
Modifications of the hydrolysis protocol
were applied for the analysis of MSO and
tryptophan contents. For determination of
MSO, the samples were hydrolyzed in liquid
phase using 4 M NaOH at 115C for 24 h. For
tryptophan analysis, the samples were hydro-
lyzed in liquid phase using 3 M mercapto-
ethane sulfonic acid at 115C for 24 h. After
hydrolysis the acid was neutralized by addi-
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tion of equal volume of 4 M NaOH. In both
cases the resulting solutions were then evapo-
rated on a vacuum concentrator, derivatized
and analyzed as above.
RESULTS
Determination of the oxidation state of
amino-acid residues in chemically oxidized
kininogens
The results obtained from amino acid analy-
sis of the samples of HK that were oxidized
with 0.625 mM NCS (250 molar excess over
protein) and then were subjected to hydrolysis
under various conditions, are presented in
Table 1. After standard acid hydrolysis, the
amino-acid composition of oxidized HK was
insignificantly different from that of the na-
tive protein. However, this method does not
allow one to quantify the content of MSO that
is converted with a variable yield to methio-
nine during acid hydrolysis. Hence, samples
of NCS-oxidized HK were also subjected to al-
kaline hydrolysis to separately analyze for
MSO and methionine contents. In oxidized
HK, the determined amount of MSO was at
least 86% of the methionine content of native
HK. No residual methionine was detected in
oxidized HK. Similar results were obtained
upon analysis of oxidized LK (not shown).
These data suggest a nearly full conversion of
methionine to MSO upon kininogen oxidation
with NCS. Only slightly lower methionine oxi-
dation extent (at least 70%) was determined in
CT-oxidized HK (not shown). Another method
of hydrolysis (in 3 M mercaptoethane sulfonic
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Table 1. Changes in amino-acid composition of high molecular mass kininogen after its oxidation
with NCS.
HK (2.5 M) was modified with 0.625 mM NCS in 0.05 M Hepes buffer pH 7.0, containing 0.15 M NaCl, for 2 h at
37C and then the reaction was quenched with 9 mM methionine for 0.5 h at the same temperature. Samples of mod-
ified HK and of native HK were extensively dialyzed against water and hydrolyzed at 115C, 24 h by three different
hydrolytic agents. Amino acid analysis was performed according to the Waters Pico-Tag protocols. Data are means
from duplicate determinations.
a
Expressed relative to the methionine content in native HK sample subjected to alkaline hydrolysis.
acid) was applied to determine the content of
tryptophan in native and NCS-modified kini-
nogens. About 32% of Trp residues seemed to
undergo NCS-mediated modification.
Although the results of amino acid analysis
suggested complete oxidation of kininogen
methionine residues by NSC, additional anal-
ysis was performed to confirm the oxidation
state of Met-361, one adjacent to the N-ter-
minus of the internal kallidin sequence in
kininogen. A sample of NCS-oxidized HK was
first digested with human neutrophil elastase
(HNE) that had previously been reported to
cleave the peptide bond of kininogen after
Ile-358 (Sato & Nagasawa, 1988; Imamura et
al., 2002). After further action of HPK that
should expose the kinin C-terminus, the sam-
ple was analyzed in a specifically dedicated re-
versed-phase HPLC system. On the chroma-
tograms obtained (Fig. 1) a species is visible
with the retention time identical to that of the
peptide SL(MSO)KRPPGFSPFR that is gen-
erated upon a short treatment of the peptide
SL(MSO)KRPPGFSPFRSSRI with HPK.
These data suggest, at least qualitatively, that
Met-361 is oxidized in NCS-oxidized HK.
Kinin formation from chemically oxidized
kininogens by plasma- and tissue
kallikreins
Time courses for bradykinin production
from native and NCS-oxidized HK by HPK
and for kallidin formation from native and
NCS-oxidized kininogens (HK and LK) by a
tissue kallikrein (PPK) are shown in Fig. 2.
Kinin production was strongly quenched after
substrate oxidation. However, this effect was
rather moderate in the tissue kallikre-
in-dependent system as compared to the
nearly complete abolishment of bradykinin
production by HPK from NCS-oxidized HK.
As shown in Fig. 3A, quite a low molar excess
of the oxidizing agent (28-fold over kininogen,
i.e. 3.5-fold over methionine residues) was suf-
ficient to lower the kinin yield by about 50%.
At these low NCS concentrations no differ-
ence between the actions of plasma and tissue
kallikreins on the oxidized substrate was de-
tectable. As NCS excess increased, the kalli-
din yield in the tissue-kallikrein system
seemed to stabilize at the level of about 30% of
that for native kininogen (HK or LK); how-
ever, the bradykinin formation from HK by
HPK fell down to a really residual yield at
NCS concentration higher than 2 mM. When
CT was used for kininogen oxidation, the de-
pendence of kinin yield on the oxidant concen-
tration (Fig. 3B) was quantitatively similar be-
tween the HK-HPK and LK-PPK systems.
Moreover, it essentially matched the charac-
teristics obtained for the tissue kallikrein-de-
pendent processing of NCS-modified kinino-
gens; at the highest CT concentration the
kinin production reached 30% of that from na-
tive substrate.
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Figure 1. Chromatographic confirmation of the
oxidation state of Met-361 in NCS-oxidized HK.
Oxidized kininogen (1 M) was incubated in 0.05 M
Hepes buffer pH 7.0, containing 0.15 M NaCl, with
HNE (0.02 M) for 2 h at 37C and then with HPK (0.05
M) at the same temperature. After specified time of
kallikrein treatment, the reaction was stopped with 1 M
HCl (one-fifth volume) and samples were analyzed by
reversed-phase HPLC in isocratic water/metha-
nol/TFA system (42% methanol). Dotted/dashed line,
sample just after HNE treatment; dashed and solid
lines, sample treated with HNE and then with HPK for
15 min and 60 min, respectively; dashed line, the pep-
tide SL(MSO)KRPPGFSPFRSSRI (5 M), treated with
HPK (0.05 M) in 0.05 M Hepes buffer pH 7.0, contain-
ing 0.15 M NaCl, for 5 min at 37C.
Pre-HPK binding to native and oxidized HK
The results of high-performance gel filtra-
tion of mixtures of pre-HPK with native or oxi-
dized HK are presented in Fig. 4. Pre-HPK
(molecular mass 85 kDa) was applied in a 1.5
molar excess over kininogen (molecular mass
120 kDa). Analysis of the samples containing
pre-HPK with native HK revealed two peaks
with apparent molecular masses of 220 kDa
and 85 kDa. The first one seemed to represent
a complex of both components, the second
was of the prekallikrein excess. Essentially
the same elution profile was obtained for the
mixtures of pre-HPK with CT-oxidized HK,
clearly indicating that the modified kininogen
retained full capability of pre-HPK binding. In
sharp contrast, an insignificant amount of the
220 kDa species could be detected upon analy-
sis of mixtures of pre-HPK with NCS-oxidized
HK. Thus, NCS-modified HK seemed to be un-
able to form a stable complex with pre-HPK.
Inhibition of papain by native and oxidized
kininogens
The characteristics of papain inhibition
(Fig. 5) were essentially indistinguishable be-
tween native kininogens (HK or LK) and
kininogens subjected to oxidation with NCS at
submillimolar concentrations. The inhibitory
capability was slightly impaired only at the
NCS concentrations higher than 6 mM, i.e. ex-
ceeding 10-fold the levels used in all experi-
ments described in the previous sections. Sim-
ilarly, a complete resistance of the papain-in-
hibitory activity of kininogens toward oxida-
tion by CT was determined (not shown). In
control experiments it was shown that under
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Figure 2. Time-course of kinin formation from na-
tive and NCS-oxidized kininogens by kallikreins.
Kininogens (1 M) were treated with kallikreins (0.05
M) in 0.05 M Hepes buffer pH 7.0, containing 0.15 M
NaCl, at 37C. After specified time, aliquots of the incu-
bation mixtures were withdrawn, mixed with one-fifth
volume of 1 M HCl to stop the reaction, and then were
analyzed by reversed-phase HPLC for bradykinin or
kallidin contents. Empty symbols, native kininogens;
filled symbols, oxidized kininogens; squares, HK pro-
cessed with HPK; triangles, HK processed with PPK;
circles, LK processed with PPK.
Figure 3. Dependence of kinin formation from ox-
idized kininogens upon the concentration of oxi-
dizing agents: NCS (A) or CT (B).
Native or oxidized kininogens (1 M) were treated with
kallikreins (0.05 M) for 15 min at 37C and then sam-
ples were analyzed by reversed-phase HPLC for kinin
content. Squares, HK treated with HPK; triangles, HK
treated with PPK; circles, LK treated with PPK.
conditions required for papain activation (5
mM cysteine, 37C, 1 h) the model peptide
SL(MSO)KRPPGFSPFRSSRI could not be
converted to SLMKRPPGFSPFRSSRI in any
significant yield. Hence, the possibility of a re-
versal of kininogen oxidation during the
papain inhibition assay was definitely ex-
cluded.
DISCUSSION
Reactive oxygen species that may occur in
the living organism have an oxidative poten-
tial sufficient to convert methionine residues
to MSO (Vogt, 1995). Further oxidation to
methionine sulfone is unlikely to proceed in
vivo. Of the chemicals commonly used for pro-
tein oxidation for the purposes of structural
studies, NCS and CT were reported to be satis-
factorily specific toward methionine (Schecht-
er et al., 1975) and to be effective at submilli-
molar concentrations that might be suffi-
ciently non-destructive to the protein native
conformation. Both reagents oxidize methio-
nine to MSO; hence, in terms of the product
formed, the modified protein may have some
biological relevance. Moreover, chemical
properties of CT resemble to some degree
those of numerous chloramines that may be
formed in vivo by the action of hypochlorous
acid on biological amines. Obviously, both
NCS and CT also oxidize cysteine residues if
present in the protein being modified. How-
ever, all cysteine residues of kininogens are
involved in disulfide bridges so that no free
sulfhydryl group occurs in the protein mole-
cule (Colman, 1994). Another, although physi-
ologically perhaps less relevant, side reaction
of NCS is the modification of tryptophan resi-
dues (Schechter et al., 1975). This type of mod-
760 M. Nizio³ek and others 2003
Figure 5. Inhibition of papain by native or oxi-
dized HK.
In the wells of a standard microplate, 5 l of papain so-
lution (1.25 mg/ml in 0.05 M sodium phosphate buffer
pH 6.8, containing 10 mM EDTA and 5 mM cysteine)
were mixed with 3–20 l native or NCS-oxidized HK
(2.5 M) and the phosphate buffer in a total 200 l vol-
ume. After incubation for 30 min at 37C, 4 l of
BAPNA solution (50 mM in Me2SO) was added and the
increase of absorbance at 410 nm was continuously fol-
lowed. Empty squares, dotted line, native HK; filled
squares, solid line, HK oxidized with 0.625 mM NSC
(i.e. at a 250 molar excess of the oxidizing agent over
kininogen); circles, dashed line, HK oxidized with 2
mM NCS; triangles, dashed/dotted line, HK oxidized
with 6.25 mM NCS.
Figure 4. Gel filtration analysis of mixtures of
pre-HPK with native and oxidized HK.
HK (2.5 M) was oxidized with NSC (0.625 mM) or CT
(0.57 mM). Pre-HPK (1.5 M) was incubated with na-
tive or oxidized kininogen (1 M) in 0.05 M Hepes
buffer pH 7.0, containing 0.15 M NaCl for 1 h at room
temperature and then samples (200 l) were subjected
to high-performance gel filtration on a Superdex-200
HR 10/30 column eluted with 0.05 M sodium phos-
phate buffer pH 7.0, containing 0.15 M NaCl, at a flow
rate of 0.5 ml/min. The column was pre-calibrated with
a mixture of standard proteins of molecular masses in-
dicated. Solid line, pre-HPK + native HK; dashed line,
pre-HPK + NCS-oxidized HK; dotted line, pre-HPK +
CT-oxidized HK.
ification is less likely when CT is used for pro-
tein oxidation (Schechter et al., 1975).
Methionine residues are located at very stra-
tegic points on the kininogen molecule
(Colman, 1994). Two of them (Met-357 and
Met-361) occur in the small kinin-containing
domain D4; the latter residue is directly adja-
cent to the internal kinin sequence (residues
362–371). Previous studies on model peptides
suggested that conversion of the hydrophobic
Met-361 residue to the more polar MSO
should quench the release of kinin N-terminus
by both types of kallikreins. In this work we
qualitatively confirmed the oxidation of
Met-361 in NCS-modified kininogens. As
judged from direct analysis of amino-acid
composition of NCS-modified kininogen,
nearly all methionine residues seemed to be
oxidized by this reagent. Hence, the oxidation
of Met-361 might be the primary structural
reason of the ineffective processing of NCS-
and CT-oxidized kininogens by kallikreins. In
this work, the quenching of kinin release was
confirmed for all kininogen-kallikrein combi-
nations except for the physiologically insignif-
icant LK-HPK pair. This quenching effect was
observed at a relatively low molar excess of
the oxidizing agents over the protein, suggest-
ing an exceptionally high susceptibility of
Met-361 toward oxidation. This high reactiv-
ity is rather expected as Met-361 should be lo-
cated in a loop that must be sufficiently ex-
posed to the solvent to be accommodated by
the active site of kallikrein.
No significant difference in the magnitude of
the quenching effect on kinin release was de-
tected between NCS- and CT-oxidized kini-
nogens (HK or LK) in the process performed
by tissue kallikrein. This indicates that the
smaller overall extent of methionine oxidation
by CT is not essential for the impairment of
the kinin-precursor property of oxidized HK
and LK.
The clearly much stronger effect of NCS-oxi-
dation of HK on bradykinin release from this
substrate by HPK may be through a possible
impairment of HPK binding to HK. Forma-
tion of this tight complex is a prerequisite for
the effective catalytic action of HPK on HK
(Bhoola et al., 1992; Colman & Schmeier,
1997). We found that NCS-oxidized HK had
no capability of pre-HPK binding, in sharp
contrast to CT-oxidized HK that bound
pre-HPK as tightly as native HK. In the HK
molecule, three methionine residues
(Met-554, Met-555 and Met-613) flank the re-
gion responsible for pre-HPK binding. Al-
though neither is located within the binding
region (residues 565–595), their conversion
to polar MSO residues may have a significant
effect on the overall conformation of the D6
domain. Then, however, some effect of CT-mo-
dification of HK on pre-HPK binding should
probably be detectable. Unfortunately, a sin-
gle tryptophan residue (Trp-569) is located
just in the contact region. Modification of this
residue by NCS, not just oxidation of the Trp
side chain but even cleavage of the peptide
bond adjacent to this residue, could be ex-
pected to completely cancel the possibility of
this protein–protein interaction. Moreover,
another tryptophan residue (Trp-601) is in the
vicinity of the pre-HPK region at the C-ter-
minal side. We detected a significant modifi-
cation of tryptophan residues in NCS-oxidized
HK, although no attempts to assign this modi-
fication to specific residues in the pre-HPK re-
gion were made. Anyhow, it should be empha-
sized that the tight complex with pre-HPK is
the natural form of HK and in this complex
the residues present in/at the binding region
are expected to be protected from oxidation
under mild conditions. Thus it is rather oxida-
tion of HK by CT that may be considered as a
model of oxidative quenching of bradykinin
formation in vivo.
Another activity of kininogens (both HK and
LK), inhibition of cysteine proteinases, was
found insensitive toward oxidation by NCS or
CT when papain was used as a model enzyme.
Met-160 is located at the N-terminal part of
the inhibitory domain D2 and Trp-204 at the
C-terminal end of this domain. Some decrease
of the papain-inhibiting capability was only
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observed in HK oxidized with exceptionally
high NCS concentration. Although under
those conditions Trp-204 might be modified,
non-specific denaturation of some kininogen
molecules was more likely.
Taken together, our results indicate that
mild oxidation of kininogens, via conversion
of methionine residues to MSO residues, re-
sults in a selective quenching effect on kinin-
precursor properties of these multifunctional
proteins. Other biologically essential kinino-
gen functions, interaction of HK with plasma
prekallikrein (and probably the entire pro-coa-
gulation function of HK) and inhibition of
cysteine proteinases by both HK and LK, may
be preserved. A biological significance of
those findings remains yet to be established.
It is possible that quenching of kinin release
at the inflammatory foci due to the action of
reactive oxygen species released by phago-
cyting neutrophils may help to stop kinin pro-
duction at late stages of inflammatory reac-
tion and to initiate the tissue restoration.
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